CORRECTION article

Front. Cardiovasc. Med., 10 May 2022

Sec. Cardio-Oncology

Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.920605

Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey

On behalf of ANMCO Cardio-Oncology Task Force
  • 1. Division of Cardiology, Azienda USL Toscana Nord-Ovest, Versilia Hospital, Lido di Camaiore, Italy

  • 2. Cardiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • 3. Cardiology Unit, Oncology Department, CRO National Cancer Institute, Aviano, Italy

  • 4. Divisione di Cardiologia, Ospedale Mauriziano, Turin, Italy

  • 5. Medical Oncology, Azienda USL Toscana Nord-Ovest, Versilia Hospital, Lido di Camaiore, Italy

  • 6. SC Centro Cardiovascolare Ospedale Maggiore, Trieste, Italy

  • 7. Division of Cardiology, San Filippo Neri Hospital, ASL Roma 1, Rome, Italy

  • 8. Division of Cardiology, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy

  • 9. Division of Cardiology, Garibaldi-Nesima Hospital, Catania, Italy

  • 10. UOSD Cardiologia di Interesse Oncologico - IRCCS Istituto Tumori “GIOVANNI Paolo II” Bari, Bari, Italy

  • 11. Division of Cardiology, Arcispedale S. Maria Nuova, Azienda USL – IRCCS di Reggio-Emilia, Reggio-Emilia, Italy

  • 12. S.C. Cardiologia, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Napoli, Italy

  • 13. UOC Ematologia, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy

  • 14. Servizi Cardiologici Integrati, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy

Article metrics

View details

1,1k

Views

417

Downloads

In the original article, there were errors in “affiliations 10 and 11. Instead of “Division of Cardiology, Istituto Tumori Giovanni Paolo II, Bari, Italy,” it should be “UOSD Cardiologia di Interesse Oncologico - IRCCS Istituto Tumori “GIOVANNI Paolo II” Bari, Bari, Italy.”

Instead of “Divisione di Cardiologia, Arcispedale S. Maria Nuova, Reggio-Emilia, Italy,” it should be “Division of Cardiology, Arcispedale S. Maria Nuova, Azienda USL – IRCCS di Reggio-Emilia, Reggio-Emilia, Italy.”

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

cardio-oncology, anthracyclines, trastuzumab, global longitudinal strain, cardiac biomarker, healthcare

Citation

Canale ML, Turazza F, Lestuzzi C, Parrini I, Camerini A, Russo G, Colivicchi F, Gabrielli D, Gulizia MM, Oliva S, Tarantini L, Maurea N, Rigacci L, Petrolati S, Casolo G and Bisceglia I (2022) Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey. Front. Cardiovasc. Med. 9:920605. doi: 10.3389/fcvm.2022.920605

Received

14 April 2022

Accepted

19 April 2022

Published

10 May 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

9 - 2022

Updates

Copyright

*Correspondence: Maria Laura Canale

This article was submitted to Cardio-Oncology, a section of the journal Frontiers in Cardiovascular Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics